I understand and have empathy for all feeling anxiety right now as you well know from all of the private messages we've exchanged, but I'm sorry my friend, you definitely WERE GAMBLING right from day one when you plunked down all of that cash on a small startup play that didn't have a parent company with deep pockets to fund the efforts of it's fledgling. A fledgling that was diving into a very new, difficult, and uncertain market.

I still believe you'll become very happy once all details are revealed and revenue growth can finally be seen. Also, I believe Dadon was most likely not yanking anybody's chain when he stated that a big part of the delay to the audited financial reports was an SEC technicality over the purchase of the bottling equipment.

Apparently the company (Raw Pharma, LLC) apparently "liquidated" when they sold all of their assets to RMHB back in May https://www.otcmarkets.com/stock/RMHB/news/Ro...?id=261667 , I thought the company was dissolved as opposed to RMHB purchasing another wholly owned subsidiary, or at least I believe that was the intention since RMHB management wanted to create the new Rocky Mountain Productions, Inc., and to not keep the name of the company selling the assets.

Not surprised at all by the emergence of a pain in the ass SEC technicality. At one point they had an SEC expert assisting them, but I'm not sure if he was involved when this deal went down. Anyhow, no sense finger pointing now. They weren't trying to hide failure by not reporting, as the only failure was to report, not a train wreck. It should be sweet once fully audited reports are in the hands of the SEC with corrections made and all necessary forms submitted and approved.

Remember, this is merely a technical SEC reporting oversight and not a train wreck where production or distribution was halted. Revenue growth was taking place.